Dec 2, 2020 7:57 AM
BACK TO TOP
KSE100
41,665.27
596.45
(1.45%)
ALLSHR
29,204.74
355.28
(1.23%)
KSE30
17,533.49
251.98
(1.46%)
KMI30
67,147.45
829.35
(1.25%)
BKTi
12,698.53
114.39
(0.91%)
OGTi
13,181.41
99.89
(0.76%)
KMIALLSHR
20,551.88
230.25
(1.13%)
UPP9
11,824.68
184.06
(1.58%)
NITPGI
8,977.42
113.81
(1.28%)
NBPPGI
10,293.14
129.70
(1.28%)
MZNPI
9,942.87
122.98
(1.25%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.742.45
3.93
(0.53%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Tue, Dec 1, 2020 4:09 PM
REG
FUT
ODL
Open
740.00
High
747.00
Low
730.00
Volume
35,900
CIRCUIT BREAKER
686.77 — 798.13
DAY RANGE
730.00 — 747.00
52-WEEK RANGE
309.00 — 785.00
Ask Price
742.45
Ask Volume
500
Bid Price
0.00
Bid Volume
0
LDCP
742.45
VAR
10.50
HAIRCUT
15.00
P/E Ratio (TTM)
20.00
1-Year Change *
64.19%
YTD Change *
66.18%
Open
729.00
High
729.00
Low
729.00
Close
729.00
Change
-1.27%
LDCP
0.00
Volume
1
Total Trades
1
CIRCUIT BREAKER
668.21 — 816.70
DAY RANGE
729.00 — 729.00
Ask Price
738.00
Ask Volume
1
Bid Price
722.01
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited (the Company) is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of research based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Mr. Munir A. ShaikhChairperson
Mr. Syed Anis AhmedCEO
Mr. Humayun AltafCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Associates (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
72,686,079.22
Shares
97,900,302
Free Float
21,034,489
Free Float
21.49%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 29, 2020Transmission of Quarterly Report for the Period Ended September 30, 2020 View   PDF
Oct 28, 2020Financial Result for the Quarter Ended September 30th, 2020 View   PDF
Aug 28, 2020Transmission of Quarterly Report for the Period Ended June 30, 2020 View   PDF
Aug 28, 2020Financial Results for the Quarter Ended June 30th, 2020 View   PDF
Jun 1, 2020Transmission of Quarterly Report period ended View   PDF
Jun 1, 2020Financial Results for the 1st Quarter View   PDF
May 29, 2020Quarterly Report for the period ended March 31st, 2020 View   PDF
May 29, 2020Financial Result for the 1st Quarter View   PDF
Apr 8, 2020Grant of Extension for filing Financial Statements for the First Quarter ended on 31 March 2020 View   PDF
Apr 6, 2020Extension for filing Financial Statements for the First Quarter ended on 31 March 2020 View   PDF
DateTitleDocument
Oct 20, 2020Board Meeting View   
Aug 20, 2020Board Meeting View   PDF
May 28, 2020Board Meeting in Progress View   
May 21, 2020Board Meeting View   
May 5, 2020Notice of Annual General Meeting View   PDF
Mar 18, 2020Notice of Annual General Meeting View   PDF
Feb 24, 2020Board Meeting View   
Oct 10, 2019Board Meeting View   
Aug 9, 2019Board Meeting View   
Apr 16, 2019Board Meeting View   
DateTitleDocument
Sep 18, 2020Dispatch of Interim Cash Dividend View   
Jun 11, 2020Dispatch of Final Dividend Warrants View   
May 29, 2020Re-Appointment of Chief Executive View   PDF
May 29, 2020Re-Appointment of Chairman View   PDF
May 28, 2020Election of Directors View   PDF
May 20, 2020Notice Election of Directors View   PDF
May 13, 2020Addendum to AGM Notice View   PDF
Apr 3, 2020Postponement of the 71st AGM of Abbott Laboratories (Pakistan) Limited View   PDF
Mar 30, 2020Dissemination of the Annual Report of Abbott Laboratories Pakistan Limited View   PDF
Jan 17, 2020Appointment of Company Secretary View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales30,155,87529,719,27926,088,23323,387,915
Profit after Taxation1,299,8852,694,3334,205,2324,021,792
EPS13.2827.5242.9541.08
Q3 2020Q2 2020Q1 2020Q3 2019
Sales8,438,2418,472,1788,061,4936,974,831
Profit after Taxation985,4441,257,547862,517265,791
EPS10.0712.858.812.71
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)28.2832.8938.6740.05
Net Profit Margin (%)4.319.0716.1217.20
EPS Growth (%)(51.74)(35.93)4.5512.12
PEG(0.66)(0.64)3.571.92

Payouts

DateFinancial ResultsDetailsBook Closure
August 28, 2020 12:14 PM30/06/2020(HYR) 150% (i) (D) 09/09/2020 - 16/09/2020
March 2, 2020 3:11 PM31/12/2019(YR) 75%(F) (D) 20/05/2020 - 27/05/2020
February 21, 2019 3:04 PM31/12/2018(YR) 100%(F) (D) 16/04/2019 - 23/04/2019
August 17, 2018 3:07 PM30/06/2018(HYR) 100% (D) 04/09/2018 - 11/09/2018
February 26, 2018 3:36 PM31/12/2017(YR) 300% (D) 14/04/2018 - 23/04/2018
August 21, 2017 3:09 PM30/06/2017(HYR) 100% (D) 08/09/2017 - 15/09/2017
February 27, 2017 5:03 PM31/12/2016(YR) 300% (D) 11/04/2017 - 18/04/2017
August 19, 2016 3:32 PM30/06/2016(HYR) 100% (D) 06/09/2016 - 16/09/2016
February 19, 2016 4:19 PM31/12/2015(YR) 200% (D) 14/04/2016 - 21/04/2016
August 17, 2015 1:36 PM30/06/2015(HYR) 100% (D) 04/09/2015 - 11/09/2015

Financial Reports